Matador Resources (NYSE:MTDR) reported quarterly earnings of $2.68 per share which beat the analyst consensus estimate of $2.50 by 7.2 percent. This is a 114.4 percent increase over earnings of $1.25 per share from the same period last year.
Reported Late Monday, Kazia Therapeutics Announces Research Collaboration With QIMR Berghofer Medical Research Institute To Investigate The Utility Of Its Lead Asset, Paxalisib In Solid Tumors
Kazia Therapeutics has announced a research collaboration with QIMR Berghofer Medical Research Institute (an Australia-based cancer research center) to investigate the utility of its lead asset, paxalisib (PI3K/mTOR